Smart Technologies in Early Post-Stroke Rehabilitation
SMART-Stroke
Changes in Biosocial and Cognitive Functions and Quality of Life When Applying Different Smart Technologies in Stroke Patients During Early Rehabilitation
1 other identifier
interventional
200
1 country
2
Brief Summary
The goal of this interventional study is to evaluate the impact of applying different smart technologies during early rehabilitation after stroke. The primary hypothesis is that the use of smart technologies in the early stage of rehabilitation will significantly improve biosocial and cognitive functions, quality of life, and participation in activities. Furthermore, the extent of these improvements may differ depending on the type of technology used and individual patient characteristics. The specific aims of the study are:
- To evaluate changes in biosocial and cognitive functions in stroke patients using different smart technologies during early rehabilitation.
- To assess changes in quality of life and participation in daily activities.
- To compare the effectiveness of different smart technologies on recovery outcomes.
- To identify patient-specific factors influencing rehabilitation results. A total of four groups will be studied. Three experimental groups will receive interventions with different interactive rehabilitation technologies (RecoveriX, Gloreha Aria, E-Link). The control group will undergo standard occupational therapy. All groups will receive the same level of conventional rehabilitation and medical care. Assessments will be conducted at the beginning and end of the 6-7 week rehabilitation program, covering motor, cognitive, and biosocial functioning, as well as quality of life. The results are expected to provide new knowledge on the effectiveness of smart technologies in stroke rehabilitation, to guide the development of personalized rehabilitation programs, and to support evidence-based decisions for occupational therapy and health care practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Sep 2025
Typical duration for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2025
CompletedFirst Posted
Study publicly available on registry
September 12, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
September 12, 2025
September 1, 2025
3 years
August 28, 2025
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in biosocial functions
Measured using the Functional Independence Measure (FIM), a standardized tool assessing functional independence in activities of daily living. Scores range from 18 to 126, with higher scores indicating greater functional independence.
Baseline (Day 1) and after 6 weeks of rehabilitation.
Change in cognitive functions
Measured using the Montreal Cognitive Assessment (MoCA), a screening tool for cognitive impairment. Scores range from 0 to 30, with higher scores indicating better cognitive function.
Baseline (Day 1) and after 6 weeks of rehabilitation.
Change in quality of life
Measured using the Short Form-36 (SF-36) questionnaire. Scores range from 0 to 100 for each domain, with higher scores indicating better quality of life.
Baseline (Day 1) and after 6 weeks of rehabilitation.
Secondary Outcomes (7)
Change in pain and fatigue levels
Baseline (Day 1) and after 6 weeks of rehabilitation.
Change in motivation and willpower
Baseline (Day 1) and after 6 weeks of rehabilitation.
Participation in daily activities
Baseline (Day 1) and after 6 weeks of rehabilitation.
Upper extremity motor function
Baseline (Day 1) and after 6 weeks of rehabilitation.
Gross manual dexterity
Baseline (Day 1) and after 6 weeks of rehabilitation.
- +2 more secondary outcomes
Study Arms (4)
RecoveriX Group
EXPERIMENTALStroke patients receiving interactive rehabilitation with the RecoveriX brain-computer interface (BCI) system. Duration: 6-7 weeks, in addition to conventional rehabilitation.
Gloreha Aria Group
EXPERIMENTALStroke patients receiving robotic-assisted therapy with the Gloreha Aria system. Duration: 6-7 weeks, in addition to conventional rehabilitation.
E-Link Group
EXPERIMENTALStroke patients receiving computer-based interactive training with the E-Link system. Duration: 6-7 weeks, in addition to conventional rehabilitation.
Standard Occupational Therapy Group
ACTIVE COMPARATORStroke patients receiving conventional occupational therapy only. Duration: 6-7 weeks.
Interventions
RecoveriX is a brain-computer interface (BCI) system designed for motor rehabilitation after stroke. It records brain activity using EEG and provides real-time feedback through virtual reality and functional electrical stimulation (FES). Participants imagine hand movements, and the system activates corresponding virtual movements and stimulates the muscles to support motor recovery.
Gloreha Aria is a robotic therapy system for upper limb rehabilitation. It combines mechanical assistance with virtual reality tasks to restore hand and finger movements. The device can be used in passive, assistive, or active modes, depending on the patient's abilities, and provides interactive exercises to improve motor function and neuroplasticity.
E-Link is an interactive computer-based system for hand and finger rehabilitation. It uses sensors to capture movements and provides individualized motor training through interactive tasks. The system allows both active motor practice and objective assessment of fine motor skills and functional abilities.
The control group will receive conventional occupational therapy as part of standard rehabilitation. Therapy will include individualized exercises to improve motor, cognitive, and functional abilities, consistent with usual clinical practice.
Eligibility Criteria
You may qualify if:
- Signed informed consent.
- Ischemic stroke confirmed by imaging (CT or MRI).
- Hemiplegia/hemiparesis with arm motor deficit (muscle strength ≤ 4 points on Lovett scale).
- Time since stroke ≤ 1 month.
- No severe cognitive impairment (MMSE ≥ 18).
- Native Lithuanian speaker.
You may not qualify if:
- Declines participation.
- Contraindications for RecoveriX (metallic implants in the head, cochlear implants, cardiac pacemaker).
- Previous craniotomy or severe head trauma with loss of consciousness.
- Epilepsy or history of seizures.
- Severe aphasia or severe comprehension impairment (MMSE \< 18).
- Severe comorbidities affecting biosocial functions.
- Previous significant arm function deficits unrelated to stroke.
- Severe visual or hearing impairments interfering with participation.
- Unilateral neglect syndrome (Hemispatial neglect).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Neurorehabilitation Department
Kaunas, Kauno, 50161, Lithuania
Lithuanian University of Health Sciences, Hospital Kaunas Clinics, Kulautuva Rehabilitation Hospital
Kaunas, Kauno, 53483, Lithuania
Related Publications (1)
Endzelyte E, Petruseviciene D, Kubilius R, Mingaila S, Rapoliene J, Rimdeikiene I. Integrating Brain-Computer Interface Systems into Occupational Therapy for Enhanced Independence of Stroke Patients: An Observational Study. Medicina (Kaunas). 2025 May 21;61(5):932. doi: 10.3390/medicina61050932.
PMID: 40428890BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vaiva Lesauskaitė, Prof. habil. dr.
Lithuanian University of Health Sciences (LSMU)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to group assignment; participants and care providers will be aware of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
August 28, 2025
First Posted
September 12, 2025
Study Start
September 15, 2025
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
September 12, 2025
Record last verified: 2025-09